Juho Joutsa
MD, PhD, Professor of Neurology
Turku Brain and Mind Center jtjout@utu.fi Kiinamyllynkatu 10 Turku |
Neurology, Movement disorders, Neuroimaging, Brain stimulation
Professor of Neurology, Clinical Neurosciences, University of Turku, 2023-
Chief neurologist, Neurocenter, Turku University Hospital, 2023-
Associate Professor, Neuroimaging, Turku Brain and Mind Center, University of Turku, 2022-2023
Assistant Professor, Neuroimaging, Turku Brain and Mind Center, University of Turku, 2019-2022
Specialist in Neurology, University on Turku, 2020
Postdoctoral Researcher (Academy of Finland) 2016-2019
Research Fellow, Massachusetts General Hospital and Harvard Medical School, 2016-2018
Adjunct Professor, Department of Neurology University of Turku, 2015-
PhD, University of Turku, 2012
MD, University of Turku, 2009
Currently, I work as Professor of Neurology at University of Turku and chief neurologist at Turku University Hospital. I lead Brain Stimulation and Neuroimaging laboratory at University of Turku (www.turkubrainlab.fi) and act as the chair of Turku Brain and Mind Center.
My research work focuses on investigating the neurobiological mechanisms of brain disorders and development of new treatment options using neuromodulation techniques. I am interested in a wide spectrum of brain disorders but especially neurological movement disorders and addictions. Our lab uses multimodal approach, combining causal brain lesions, state-of-the-art brain imaging technologies (MRI, PET, SPECT) and neuromodulation techniques (TMS, DBS, MRgFUS).
10 representative publications:
Liesmäki O, Kungshamn J, Likitalo O, Ellis EG, Bellmunt-Gil A, Aaltonen J, Steinweg I, Myller EM, Roine S, Friedrich MU, Ylikotila P, Joutsa J. Localization and network connectivity of lesions causing limb ataxia in patients with stroke. Neurology 2024;103(6)
Theys C, Jaakkola E, Melzer TR, De Nil LF, Guenther FH, Cohen AL, Fox MD, Joutsa J. Localization of stuttering based on causal brain lesions. Brain 2024;147(6):2203-13.
Honkanen EA, Rönkä J, Pekkonen E, Aaltonen J, Koivu M, Eskola O, Eldebakey H, Volkmann J, Kaasinen V, Reich MM, Joutsa J. GPi-DBS induced brain metabolic activation in cervical dystonia. J Neurol Neurosurg Psychiatry, 2024;95(4):300-8.
Joutsa J, Lipsman N, Horn A, Cosgrove GR, Fox MD. The return of the lesion for localization and therapy. Brain 2023;146(8):3146-55.
Corp DT, Greenwood C, Morrison-Ham J, Pullinen J, McDowall G, Younger E, Jinnah H, Fox MD, Joutsa J. Clinical and structural findings in patients with lesion-induced dystonia: descriptive and quantitative analysis of all published cases. Neurology 2022;99(18):1957-67.
Joutsa J, Moussawi K, Siddiqi S et al. Brain lesion disrupting addiction map to a common human brain circuit. Nature Medicine 2022;28:1249-55.
Joutsa J, Shih LC, Fox MD. Mapping Holmes’ tremor circuit using the human brain connectome. Ann Neurol 2019;86(6):812-20.
Joutsa J, Horn A, Hsu J, Fox MD. Localization of parkinsonism based on focal brain lesions. Brain 2018;141(8):2445-56.
Joutsa J, Shih LC, Horn A, Reich MM, Wu O, Rost N, Fox MD. Identifying therapeutic targets from spontaneous beneficial brain lesions. Ann Neurol. 2018;84(1):153-7.
Joutsa J, Rinne JO, Hermann B, Karrasch M, Anttinen A, Shinnar S, Sillanpää M. Association between childhood-onset epilepsy and amyloid burden 5 decades later. JAMA Neurology 2017;74(5):583-90.
Lead teacher in neurology, M.D. curriculum
- No Link Between Striatal Dopaminergic Axons and Dopamine Transporter Imagingin Parkinson’s Disease (2019)
- Movement Disorders
- Presynaptic Striatal Dopaminergic Function in Atypical Parkinsonism: A Metaanalysis of Imaging Studies (2019)
- Journal of Nuclear Medicine
- Progressive dopaminergic defect in a patient with primary progressive multiple sclerosis (2019)
- Multiple Sclerosis and Related Disorders
- Reply to: The time delay between in vivo imaging and postmortem data poses a caveat on "no link" findings (2019)
- Movement Disorders
- The effect of dopamine on response inhibition in Parkinson's disease relates to age-dependent patterns of nigrostriatal degeneration (2019)
- Parkinsonism and Related Disorders
- Beyond volume: A surface-based approach to bilingualism-induced grey matter changes (2018)
- Neuropsychologia
- Binge eating disorder and morbid obesity are associated with lowered mu-opioid receptor availability in the brain (2018)
- Psychiatry Research: Neuroimaging
- Brain amyloid load and its associations with cognition and vascular risk factors in FINGER study (2018)
- Neurology
- Bupropion causing misdiagnosis in brain dopamine transporter imaging for parkinsonism (2018)
- Movement Disorders
- Contribution of individual motor signs to striatal dopamine deficiency in parkinsonism (2018)
- Movement Disorders
- Dopamine and eye movement control in Parkinson's disease: deficits in corollary discharge signals? (2018)
- PeerJ
- Dopamine synthesis capacity correlates with µ-opioid receptor availability in the human basal ganglia: A triple-tracer PET study (2018)
- NeuroImage
- Identifying therapeutic targets from spontaneous beneficial brain lesions (2018)
- Annals of Neurology
- Lesion network localization of free will (2018)
- Proceedings of the National Academy of Sciences of the United States of America
- Localizing parkinsonism based on focal brain lesions (2018)
- Brain
- No differences in the total burden of non-motor symptoms between Parkinson's disease and non-degenerative parkinsonism (2018)
- Movement Disorders
- No Effects of Stimulating the Left Ventrolateral Prefrontal Cortex with tDCS on Verbal Working Memory Updating (2018)
- Frontiers in Neuroscience
- Psychiatric (Axis I) and personality (Axis II) disorders and subjective psychiatric symptoms in chronic tinnitus (2018)
- International Journal of Audiology
- Striatal dopamine function in multiple system atrophy and progressive supranuclear palsy: A meta-analysis of imaging studies. (2018)
- Movement Disorders
- Association Between Childhood-Onset Epilepsy and Amyloid Burden 5 Decades Later (2017)
- JAMA Neurology